The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

In partnership with the Asian Development Bank, IVAC developed factsheets and newsletters summarizing key measures for COVID-19 vaccines.

The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in South Africa in 2016.

The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in Rwanda in 2019.

This document outlines the methods used in the VIEW-hub data collection and data update process.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in Afghanistan in 2015.

The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in Uganda in 2016.

This document summarizes COVID-19 vaccine safety published studies and survey results in map form. Full results can be found on the VIEW-hub COVID safety module.

This document outlines the methods used in the COVID-19 vaccine safety survey presented in the VIEW-hub COVID safety studies module.